Effects of Huangqi （Hex） on Inducing Cell Differentiation and Cell Death in K562 and HEL Cells

InterestintraditionalChineseherbalremedieshasboomedin the western countries. It is very important to study theirmolecular mechanisms and purify effective compoundswith new knowledge and new techniques to meet a greatneed for human health. Ephedrine, the f…     

K562细胞株增殖分化相关转录因子研究进展

K562细胞作为体外研究白血病细胞增殖与分化的良好模型,其转录因子及作用机制研究是一关键的环节.本文就其中GATA、STAT、Sp家族等在K562细胞增殖分化中的作用及其相关进展作一综述.     

氧化苦参碱对K562肿瘤细胞增殖的影响

目的:研究氧化苦参碱(OM)对人白血痛细胞系K562生长增殖的影响.方法:运用MTT比色法、活细胞计数法、集落形成法以及透射电镜观察检测OM对人白血病细胞系K562增殖抑制作用.结果:MTT实验、生长曲线及集落形成实验显示OM能明显抑制K562细胞的增殖.随着OM浓度的增加,K562细胞存活细胞显著降低,呈现明显的刺量依赖性,经相关分析,细胞抑制率与OM浓度呈正相关(r=0.9010),其半数抑制浓度(IC50)为0.33 mg/ml.透射电镜下显示在低浓度即有明显的诱导细胞凋亡的作用,出现核固缩、核碎裂、凋亡小体等典型的凋亡形态.结论:OM具有抑制K562白血病细胞增殖诱导肿瘤细胞凋亡的作用.     

胆固醇对K562及耐药株K562G细胞增殖及伊马替尼敏感性的影响

目的:探讨胆固醇对K562及耐药株K562G细胞增殖及伊马替尼(Imatinib,IM)敏感性的影响。方法:通过qRT-PCR方法检测K562和K562G细胞的胆固醇代谢途径相关蛋白的表达;以不同药物组合处理K562细胞、K562G细胞,采用CCK-8方法检测细胞增殖情况。结果:耐药K562G细胞胆固醇合成酶(人角鲨烯单加氧酶SQLE,细胞色素P450酶家族51亚家族A1 CYP51A1,固醇C5去饱和酶SC5D)表达下降、而低密度脂蛋白受体LDLR、固醇酰基转移酶SOAT1、ATP结合盒转运体A1 ABCA1表达量增加;0.5μg/m L、0.75μg/m L胆固醇处理K562细胞,其增殖率比对照组K562细胞分别增加(9.51±2.84)%和(19.88±3.00)%;使用阿托伐他汀(20μM)、GW3965 (20μM)、MβCD (10 m M)降低K562G细胞胆固醇使其增殖抑制率分别为(50.73±2.34)%,(49.42±1.13)%,(76.54±1.48)%;两种浓度胆固醇使IM处理的K562细胞增殖抑制率分别减少51.59%及53.80%;MβCD联合IM使K562及K562G细胞存活率分别降低至6.89%及23.34%。结论:IM抵抗的K562G细胞与IM敏感的K562细胞相比胆固醇代谢增强;增加胆固醇能够促进K562细胞增殖,降低细胞对IM的敏感性;MβCD可能通过降低胆固醇增强K562、K562G细胞对IM敏感性。     

Cell-penetrating fusion peptides OD1 and OD2 interact with Bcr–Abl and influence the growth and apoptosis of K562 cells

The Bcr–Abl oncoprotein is the cause of chronic myelogenous leukemia (CML). Crystal structure analysis suggests that Bcr_30–63 is the core of the Bcr–Abl oligomerization interface for aberrant kinase activity; however, the precise role of other residues of Bcr_1–72 excluding Bcr_30–63 have not been evaluated. In this study, Bcr_30–63 was named OD2 and other residues of Bcr_1–72 were named OD1. Cytoplasmic transduction peptide (CTP) was used to carry molecules into cytoplasm. CTP-OD1 and CTP-OD2 fusion peptides were expressed from a cold-inducible expression system. Our results demonstrated that both fusion peptides could localize into the cytoplasm, specifically interact with the Bcr–Abl protein and further inhibit growth, induce apoptosis, and decrease the phosphorylation of Bcr–Abl in K562 cell lines. However, the viability of THP-1, a Bcr–Abl negative cell line, was unaffected. These results suggested that CTP-OD1 and CTP-OD2 may be an attractive therapeutic option to inhibit the activation of Bcr–Abl kinase in CML.     

Niflumic Acid Affects Store-Operated Ca2+-Permeable (SOC) and Ca2+-Dependent K+ and Cl− Ion Channels and Induces Apoptosis in K562 Cells

Non-steroidal anti-inflammatory drugs (NSAIDs) are known to induce apoptosis in a variety of cancer cells. However, the precise mechanisms by which NSAIDs facilitate apoptosis in tumor cells are not clear. In the present study, we show that niflumic acid (NA), a member of the fenamates group of NSAIDs and Cl^? and Ca²⁺-activated Cl^? (CAC) channels blocker, induced apoptosis (by ~8 %, 24 h treatment) and potentiated (by 8–10 %) apoptotic effect of endoplasmic reticulum Ca²⁺ mobilizer thapsigargin (Tg) in human erythroleukemic K562 cell line. The whole-cell patch clamp and Fluo-3 flow cytometric experiments confirmed an inhibitory effect of NA (100 and 300 µM) on store-operated (SOC) channels. We also found that NA-blocked CAC channels were activated by acute application of Tg (2 µM) in K562 cells. NA blockage of CAC channels was accompanied by activation of Ca²⁺-activated K⁺ (SK4) channels. The observed effects of NA were not connected with COX-2 inhibition since 100-nM NA (IC₅₀ for COX-2 inhibition) did not induce either apoptosis or affect the channels activity. We conclude that inhibition of SOC channels plays a major role in NA-induced apoptosis. Increased apoptotic levels in Tg-treated K562 cells in the presence of NA may be due to the blockage of CAC and stimulation of SK4 channels in addition to SOC channels inhibition.     

诱导耐药K562/ADM和转基因耐药K562/MDR细胞株的生物学行为和耐药机制的比较研究

目的探讨转多药耐药基因mdr1的K562/MDR细胞株作为单机制耐药模型的可行性,为进一步研究肿瘤耐药及其逆转奠定基础。方法实验分为3部分:(1)在电子显微镜下观察慢性髓细胞白血病急性红白变敏感细胞系K562,阿霉素(adriamycin,ADM)诱导耐药细胞株K562/ADM和K562/MDR耐药细胞株的生物学行为;同时测定3种细胞系的群体倍增时间;以观察药物诱导和基因转移是否对细胞的生物学行为造成影响。(2)以K562细胞为对照,用MTT法分别测定阿霉素、柔红霉素(daunorubicin,DNR)、长春新碱(vincristine,VCR)对3种细胞的半数致死量(IC50)。(3)多药耐药相关基因与蛋白的检测。免疫细胞化学法观察mdr1基因编码的P-糖蛋白(P-gp)的表达;流式细胞术检测P-gp、bcl-2的表达百分率;生化法测定细胞内谷胱甘肽S-转移酶(GSTs)活性;RT-PCR法检测拓扑异构酶(to-poisomeraseⅡ,topoⅡ)mRNA的表达变化。结果(1)在超微结构上,K562/ADM的细胞器—线粒体出现水肿,K562和K562/MDR未见明显异常;K562的群体倍增时间为19.67±3.10d;K562/MDR为20.40±1.80d;K562/ADM为28.47±1.75d;(2)K562/ADM和K562/MDR细胞对ADM的耐药倍数分别为23.1和1.2倍;对DNR为84.9和14.4倍;对VCR为298.3和10.1倍。(3)与K562比较,K562/ADM细胞的P-gp和Bcl-2蛋白表达率高且topoⅡcDNA片段大小发生变化;K562/MDR仅P-gp表达率高。结论K562/MDR的生物学行为与亲本细胞K562相似,耐药机制单一,可作为单机制耐药模型,对某一耐药基因进行更为深入精确的研究,也可针对该耐药基因准确地筛选相应的逆转剂。     

天花粉蛋白诱发白血病细胞K562凋亡的研究

天花粉蛋白(Trichosanthin,TCS),是一种从栝楼块根内提取的核糖体失活蛋白,具有流产、抗肿瘤和抗HIV等多种生物活性。本文利用FACS检测到天花粉蛋白可使K562白血病细胞产生明显的凋亡小峰、DNA区带电泳成典型的“梯状”条带,电镜检测可观察到明显的细胞凋亡形态。这些结果表明天花粉蛋白可以诱发K562白血病细胞产生凋亡。     

抗菌肽CM4抗K562癌细胞的超微结构研究

报道了家蚕抗菌肽CM4抗K562癌细胞的体外实验研究.结果表明：纯化后的家蚕抗菌肽CM4对培养的K562(人髓样白血病细胞)有很强的杀伤作用.用扫描和透射电镜观察超微结构以及用激光共聚集显微断层图像分析,表明微量纯化的抗菌肽CM4能使K562癌细胞产生一系列的病理变化,可造成细胞高度肿胀,膜与胞质分离,细胞器和膜结构排列紊乱,细胞表面微绒毛消失,出现不规则的孔洞,细胞骨架严重破坏,膜局部结构破裂,缺损,胞浆内容物大量外泄,最终细胞解体,崩解成碎片.     

Heterogeneous binding and killing behaviour of human γ/δ-TCR+ lymphokine-activated killer cells against K562 and Daudi cells

Effector-target conjugates, formed by coincubation of lymphokine-activated killer (LAK) cells with either K562 or Daudi cells, were separated from single cells by Percoll sedimentation. The occurrence of various CD molecules (CD3, CD56, CD57, CD16, /-TCR) was compared in both fractions. Only LAK cells expressing the / T cell receptor (TCR) were found in a significantly increased percentage in fractions containing conjugates indicating that /-TCR⁺ LAK cells were preferably bound to target cells at the time of separation. In order to determine whether /-TCR⁺ LAK cells also show a preferred killing activity against the targets, cultures enriched with or depleted of /-TCR⁺ cells were established. Against K562 cells, /-TCR⁺-enriched cultures showed a greatly reduced killing activity compared to LAK bulk cultures or cultures depleted of /-TCR⁺ cells. Using Daudi cells as targets the enriched fraction revealed a slightly increased killing activity compared to bulk cultures or depleted fractions. Preincubation of /-TCR⁺ LAK cells with anti-/ or anti-CD3 mAb resulted in a distinct increase of the killing activity against K562 cells, but in only a slightly enhanced activity against Daudi cells. It is postulated that /-TCR⁺ LAK cells use the same adhesion mechanism for both targets but that only Daudi cells express a specific ligand for the /-TCR. Occupation of the /-TCR/CD3 complex by mAb, however, seems to substitute for the absent epitope on K562 cells by eliciting stimulatory signals in /-TCR⁺ LAK cells which, in combination with the binding stimulus, trigger cytolytic activity.This work was supported by the Hartmann-Müller Foundation, Zürich     

RNAi干扰Shp2基因对K562细胞增殖的抑制效应

通过RNA干扰技术沉默蛋白酪氨酸磷酸酶跏2基因,构建重纽质粒,采用实时荧光定量PCR（Real-timePCR）法、Westernblot、MTT法、流式细胞术（FCM）分别检测转染后K562细胞中bcr／abl融合基因、bcr／abl融合蛋白的表达水平、细胞生长增殖变化及细胞凋亡率,探索该基因的沉默表达对K562N胞的抑制作用。结果表明,该实验成功构建出能明显下调Shp2基因及其蛋白表达的重组质粒,转染K562细胞后,其bcr／abl融合基因及融合蛋白水平均明显降低、K562细胞增殖活力被抑制（P〈0．05）、细胞凋亡水平上升（P〈0．05）。与对照组相比,其差异具有统计学意义。提示,重组质粒可显著降低bcr／abl基因及蛋白的表达,抑制K562细胞的生物学效应,表明在细胞水平沉默Shp2有可能成为治疗慢性粒细胞白血病的有效靶点。     

构建稳定表达RFP及嘌呤霉素抗性的K562细胞株

目的构建稳定表达红色荧光蛋白（red fluorescent protein,RFP）和嘌呤霉素（puromycin）抗性的K562．PM．RFP细胞株,便于慢性粒细胞性白血病研究中K562细胞的观察和筛选。方法采用PCR法获得RFP片段,将其插入到慢病毒pGC-FU-3FLAG-IRES—Puromycin载体中获得pGC—PM—RFP重组质粒,经脂质体转染到293T细胞中获得慢病毒LV—PM—RFP,有限稀释法检测慢病毒在293T细胞中的转染效率,用包装获得的慢病毒感染K562细胞,经嘌呤霉素筛选获得RFP阳性的K562-PM—RFP细胞株。结果PCR及测序结果证实目的基因RFP正确克隆至慢病毒质粒中,经慢病毒LV—PM-RFP感染的K562细胞能在嘌呤霉素抗性培养基中存活,并稳定表达RFP。结论成功构建了慢病毒重组质粒pGC—PM-RFP,并获得了携带RFP及嘌呤霉素抗性基因的K562-PM—RFP细胞株。     

青蒿素诱导人白血病细胞K562凋亡的线粒体机制

目的:探讨青蒿素诱导人白血病细胞K562凋亡的线粒体机制.方法:用青蒿素处理K562细胞.通过MTT比色法检别细胞增殖抑制的效果;荧光显微镜观察细胞的凋亡;流式细胞术(flow cytometry,FCM)进行细胞周期分析;Western-blotting测定药物作用前后线粒体、细胞浆细胞色素C的表达.结果:青蒿素抑制K562细胞的增殖,IC5D为1.5× 10-5mol·L-1;Hoechst33342/PI双荧光染色可观察到明显的核浓缩、凝集等细胞凋亡表现;流式细胞仪检测G2期细胞比例增高,S期减少;Western-blotting检测药物处理细胞后线粒体细胞色素C表达水平下调,细胞浆出现明显细胞色素C蛋白条带.结论:青蒿素可能通过线粒体细胞色素C途径诱导K562细胞凋亡.     

腹腔巨噬细胞促进传代K562细胞系的体外增殖

在实验过程中经常遇到所要应用的靶细胞或效应细胞生长状态欠佳,如果使用这样的细胞作实验,其结果不准确,不可靠。在制备鼠-鼠杂交瘤的研究中,腹腔巨噬细胞可以支持1—10个抗体形成细胞在体少生长并分泌单克隆抗体。故我们将生长状态较差的K_(562)细胞(图1)与昆明小鼠腹腔巨噬细胞共培养7天(图2)。图1显示细胞折光性不良、形态不整存     

核仁磷酸蛋白基因突变对K562白血病细胞分化的影响

核仁磷酸蛋白基因（nucleophosmin,NPM1）突变在急性髓系白血病的发生发展中发挥着重要作用,而与白血病分化阻滞的关系尚未完全阐明。为探讨NPM1基因突变对白血病细胞体外分化的影响,将携带NPM1 A型突变（NPM1-mA）的表达质粒载体pEGFPC1-NPM1-mA转染白血病K562细胞系,构建稳定表达NPM1-mA蛋白的细胞株（K562 mA）,同时设立野生型NPM1转染组（K562 wt）、空载体转染组（K562 C1）和未处理组（K562）为对照。利用豆蔻酰佛波醇乙酯（PMA）诱导各组细胞分化,瑞氏–吉姆萨染色观察细胞分化的形态改变,计算诱导分化率;相差显微镜计数贴壁细胞数量;流式细胞术分析细胞表面分化抗原CD41的表达。结果显示,PMA作用72 h后,与对照组相比,K562 mA组细胞的诱导分化率及贴壁细胞数明显降低（P〈0.05）;同时,CD41的表达受到显著抑制（P〈0.01）。提示NPM1基因突变能够阻滞白血病细胞系K562的体外分化。     

K562细胞中锌指蛋白cDNA基因片段的克隆

 Ｋ５６２细胞中锌指蛋白ｃＤＮＡ基因片段的克隆刘智,朱定尔,谢慎思,朱小湘,肖广惠,陈汉春（湖南医科大学分子生物学研究室,长沙４１００７８）１９８５年,Ｍｉｌｌｅｒ等［１］等分离并测定了非洲爪蟾卵母细胞转录因子ⅢＡ（ＴＦⅢＡ）的ｃＤＮＡ序列,推出蛋白质...     

胡桃楸提取液诱导K562细胞凋亡机制的研究

目的：考察胡桃楸提取液是否具有诱导K562细胞p52蛋白及p21蛋白的作用,初步探讨胡桃楸提取液诱导K562细胞凋亡机制。方法：以Western-blot方法检测胡桃楸提取液对K562细胞p53蛋白及诱导K562细胞p53蛋白和p21蛋白的表达。     

原子力显微镜观测紫外线诱导的K562肿瘤细胞DNA损伤

利用彗星电泳检测出UVB、UVC短时间照射会使肿瘤细胞的DNA发生断裂,而长时间照射之后彗星电泳无法检测到碎片,推测可能是由于DNA分子交联的原因[1],国内外尚无定论.为了更直观的研究这种现象,提取了UVB,UVA照射后K562细胞的DNA,并调节到合适的浓度在原子力显微镜下观测.实验结果表明UVB对K562肿瘤细胞DNA损伤的影响呈现时间/剂量效应,较短时间照射主要产生DNA的链断裂,较长时间辐射则主要产生DNA链的交联.UVC对K562肿瘤细胞DNA的损伤大于UVB.UVC短时照射即可引起DNA的断裂和交联,较长时间辐射主要产生交联和一些断裂;长时间照射不但产生大量交联,同时有大量断裂产生,并发生凝缩和缠绕等结构破坏.